Potassium Carbonate → 6,8-diiodo-2-(propylthio)-3-[(tetrahydro-2-furanyl)methyl]-4(3H)-quinazolinone

HRID 1108254Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1108254
[I:1][C:2]1[CH:3]=[C:4]2[C:9](=[C:10]([I:12])[CH:11]=1)[NH:8][C:7](=[S:13])[N:6]([CH2:14][CH:15]1[CH2:19][CH2:18][CH2:17][O:16]1)[C:5]2=[O:20].[CH2:21](I)[CH2:22][CH3:23].C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O>[I:1][C:2]1[CH:3]=[C:4]2[C:9](=[C:10]([I:12])[CH:11]=1)[N:8]=[C:7]([S:13][CH2:21][CH2:22][CH3:23])[N:6]([CH2:14][CH:15]1[CH2:19][CH2:18][CH2:17][O:16]1)[C:5]2=[O:20]

Komponenten

5

Versuchsvorschrift

A mixture of the title compound of Step A (0.86 g, 1.67 mmol), n-propyl iodide (0.85 g, 5.02 mmol) and potassium carbonate (2.3 g, 16.7 mmol) was stirred in dimethylformamide (20 mL) at ambient temperature for approximately 4 h. The reaction mixture was then concentrated to dryness in vacuo and partitioned between 200 mL each of ethyl acetate and water. The organic phase was then separated, washed with saturated aqueous NaCl, and dried over Na2SO4. Concentration in vacuo provided 0.82 g of the title compound of Step B, a compound of the invention, as a solid melting at 108-111° C. 1H NMR (300 MHz, CDCl3): δ 1.10 (t,3H), 1.63-1.80 (m,1H), 1.80-2.14 (m,5H), 3.24-3.45 (m,2H), 3.70-3.80 (m,1H), 3.90-4.00 (m,1H), 4.10-4.21 (m,2H), 4.35-4.47 (m,1H), 8.44 (d,1H), 8.48 (d,1H).

Aufarbeitung

  1. concentrationThe reaction mixture was then concentrated to dryness in vacuo
  2. custompartitioned between 200 mL each of ethyl acetate and water
  3. customThe organic phase was then separated
  4. washwashed with saturated aqueous NaCl
  5. dry with materialdried over Na2SO4
  6. concentrationConcentration in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-a18dd21f10224723b4b5d23626b7d5a7
Quelldatensatz
uspto-grants-2000_05
Patentnummer
US06066638

Notizen zur Reaktion

Wird geladen…